Register to leave comments

  • News bot May 5, 2026, 8:59 p.m.

    🔍 Garber Alan M (Director)

    Company: VERTEX PHARMACEUTICALS INC / MA (VRTX)

    Report Date: 2026-05-01

    Transaction Summary:

    • Total transactions: 2
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 1,905

    Detailed Transactions and Holdings:

    • Acquired 472 shares of Common Stock (Direct)
      Date: 2026-05-01 | Code: A | equity_swap_involved: 0 | shares_owned_after: 7,344.00 | transaction_form_type: 4 | Footnotes: F1
    • Acquired 1,433 shares of Stock Option (Right to Buy) at $424.45 per share (Derivative)
      Date: 2026-05-01 | Code: A | Expires: 2036-04-30 | equity_swap_involved: 0 | shares_owned_after: 1,433.00 | transaction_form_type: 4 | Footnotes: F2

    Footnotes:

    • F1: Restricted stock unit award that vests, subject to certain limited exceptions, on the first anniversary of the grant date.
    • F2: Fully vested.